Archives of Physical Medicine and Rehabilitation
Volume 88, Issue 10 , Pages 1289-1297 , October 2007

Development of a French Isometric Strength Normative Database for Adults Using Quantitative Muscle Testing

  • Jean-Yves Hogrel, PhD

      Affiliations

    • Institut de Myologie, GH Pitié-Salpêtrière, Paris, France
    • Corresponding Author InformationReprint requests to Jean-Yves Hogrel, PhD, Institut de Myologie, GH Pitié-Salpêtrière, 75651 Paris Cedex 13, France
  • ,
  • Christine A. Payan, MD

      Affiliations

    • Institut de Myologie, GH Pitié-Salpêtrière, Paris, France
  • ,
  • Gwenn Ollivier, PT

      Affiliations

    • Institut de Myologie, GH Pitié-Salpêtrière, Paris, France
  • ,
  • Véronique Tanant, PT

      Affiliations

    • Centre de Référence Maladies Neuromusculaires, Hôpital de l’Archet, Nice, France
  • ,
  • Shahram Attarian, MD

      Affiliations

    • Service de Neurologie, CHU La Timone, Marseille, France
  • ,
  • Annabelle Couillandre, PhD, PT

      Affiliations

    • Institut de Myologie, GH Pitié-Salpêtrière, Paris, France
  • ,
  • Arnaud Dupeyron, MD

      Affiliations

    • Service de Neurologie, CHU de Strasbourg, Strasbourg, France.
  • ,
  • Lucette Lacomblez, MD, PhD

      Affiliations

    • Département de Pharmacologie Clinique, GH Pitié-Salpêtrière, Paris, France
  • ,
  • Valérie Doppler, MD

      Affiliations

    • Institut de Myologie, GH Pitié-Salpêtrière, Paris, France
  • ,
  • Vincent Meininger, MD

      Affiliations

    • Fédération des Maladies du Système Nerveux, GH Pitié-Salpêtrière, Paris, France
  • ,
  • Christine Tranchant, MD, PhD

      Affiliations

    • Service de Neurologie, CHU de Strasbourg, Strasbourg, France.
  • ,
  • Jean Pouget, MD

      Affiliations

    • Service de Neurologie, CHU La Timone, Marseille, France
  • ,
  • Claude Desnuelle, MD, PhD

      Affiliations

    • Centre de Référence Maladies Neuromusculaires, Hôpital de l’Archet, Nice, France

References 

  1. Cook JD, Glass DS. Strength evaluation in neuromuscular disease. Neurol Clin. 1987;5:101–123
  2. Andres P, Skerry L, Munsat T. Measurement of strength in neuromuscular diseases. In:  Munsat T editors. Quantification of neurologic deficit. Stoneham: Butterworth; 1989;p. 87–100
  3. Edwards RH. Quantitative methods of assessing skeletal muscle function for therapeutic trials. Acta Cardiomiol III. 1991;2:185–198
  4. Andres PL, Hedlund W, Finison L, Conlon T, Felmus M, Munsat TL. Quantitative motor assessment in amyotrophic lateral sclerosis. Neurology. 1986;36:937–941
  5. Iannaccone ST, Hynan LS American Spinal Muscular Atrophy Randomized Trial (AmSMART) Group. Reliability of 4 outcome measures in pediatric spinal muscular atrophy. Arch Neurol. 2003;60:1130–1136
  6. Kissel JT, McDermott MP, Mendell JR, et al. FSH-DY Group Randomized, double-blind, placebo-controlled trial of albuterol in facioscapulohumeral dystrophy. Neurology. 2001;57:1434–1440
  7. van der Kooi EL, Vogels OJ, van Asseldonk RJ, et al. Strength training and albuterol in facioscapulohumeral muscular dystrophy. Neurology. 2004;63:702–708
  8. Escolar DM, Buyse G, Henricson E, et al. CINRG Group CINRG randomized controlled trial of creatine and glutamine in Duchenne muscular dystrophy. Ann Neurol. 2005;58:151–155
  9. Munsat TL. Development of measurement techniques. Neurology. 1996;47:S83–S85
  10. Hoagland RJ, Mendoza M, Armon C, et al. Reliability of maximal voluntary isometric contraction testing in a multicenter study of patients with amyotrophic lateral sclerosis (Syntex/Synergen Neuroscience Joint Venture rhCNTF ALS Study Group). Muscle Nerve. 1997;20:691–695
  11. Mayhew JE, Florence JM, Mayhew TP, et al. Reliable surrogate outcome measures in multicenter clinical trials of Duchenne muscular dystrophy. Muscle Nerve. 2007;35:36–42
  12. Andres PL, Finison LJ, Conlon T, Thibodeau LM, Munsat TL. Use of composite scores (megascores) to measure deficit in amyotrophic lateral sclerosis. Neurology. 1988;38:405–408
  13. Munsat TL, Andres PL, Finison L, Conlon T, Thibodeau L. The natural history of motoneuron loss in amyotrophic lateral sclerosis. Neurology. 1988;38:409–413
  14. Conradi S, Ronnevi LO. Pitfalls in the evaluation of isometric strength (TQNE) data in ALS. J Neurol Sci. 1996;139(Suppl):60–63
  15. The National Isometric Muscle Strength (NIMS) Database Consortium. Muscular weakness assessment use of normal isometric strength data. Arch Phys Med Rehabil. 1996;77:1251–1255
  16. Tawil R, McDermott MP, Mendell JR, Kissel J, Griggs RC. Facioscapulohumeral muscular dystrophy (FSHD): design of natural history study and results of baseline testing (FSH-DY Group). Neurology. 1994;44:442–446
  17. The FSH-DY Group. A prospective, quantitative study of the natural history of facioscapulohumeral muscular dystrophy (FSHD): implications for therapeutic trials. Neurology. 1997;48:38–46
  18. Personius KE, Pandya S, King WM, Tawil R, McDermott MP. Facioscapulohumeral dystrophy natural history study: standardization of testing procedures and reliability of measurements (The FSH DY Group). Phys Ther. 1994;74:253–263
  19. Meldrum D, Cahalane E, Conroy R, Fitzgerald D, Hardiman O. Maximum voluntary isometric contraction: reference values and clinical application. Amyotroph Lateral Scler. 2007;8:47–55
  20. Eek MN, Kroksmark AK, Beckung E. Isometric muscle torque in children 5 to 15 years of age: normative data. Arch Phys Med Rehabil. 2006;87:1091–1099
  21. Hogrel JY, Ollivier G, Desnuelle C. [Manual and quantitative muscle testing in neuromuscular disorders (How to assess the consistency of strength measurements in clinical trials?). [French] Rev Neurol (Paris). 2006;162:427–436
  22. Meldrum D, Cahalane E, Keogan F, Hardiman O. Maximum voluntary isometric contraction: investigation of reliability and learning effect. Amyotroph Lateral Scler Other Motor Neuron Disord. 2003;4:36–44
  23. Sanjak M. Measurement of strength: pro. Amyotroph Lateral Scler Other Motor Neuron Disord. 2002;3(Suppl 1):S45–S47
  24. Sorenson E. Measurement of strength: con. Amyotroph Lateral Scler Other Motor Neuron Disord. 2002;3(Suppl 1):S49–S50
  25. Miller RG. Measurement of strength: summary. Amyotroph Lateral Scler Other Motor Neuron Disord. 2002;3(Suppl 1):S51–S54

 Supported by the Association de Recherche sur la Sclérose Latérale Amyotrophique and the Association Française contre les Myopathies.

 No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit upon the author(s) or upon any organization with which the author(s) is/are associated.

PII: S0003-9993(07)01282-8

doi: 10.1016/j.apmr.2007.07.011

Archives of Physical Medicine and Rehabilitation
Volume 88, Issue 10 , Pages 1289-1297 , October 2007